Literature DB >> 19663586

The promise of nanomedicine for ocular disease.

Heather Thomson, Andrew Lotery.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19663586     DOI： 10.2217/nnm.09.43

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   5.307


× No keyword cloud information.
  3 in total

1.  Saudi genetic ophthalmology research: The local and global impact.

Authors:  Fowzan S Alkuraya
Journal:  Saudi J Ophthalmol       Date:  2010-02-08

Review 2.  Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy.

Authors:  Artur V Cideciyan
Journal:  Prog Retin Eye Res       Date:  2010-04-24       Impact factor: 21.198

3.  Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization.

Authors:  Hani Salehi-Had; Mi In Roh; Andrea Giani; Toshio Hisatomi; Shintaro Nakao; Ivana K Kim; Evangelos S Gragoudas; Demetrios Vavvas; Samira Guccione; Joan W Miller
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.